INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 387 filers reported holding INSMED INC in Q2 2024. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $143,310,521 | +19.4% | 2,138,963 | -51.6% | 16.61% | +22.7% |
| Q1 2024 | $120,006,001 | -29.7% | 4,423,369 | -19.7% | 13.53% | -12.1% |
| Q4 2023 | $170,808,234 | +14.9% | 5,511,721 | -6.4% | 15.39% | +9.4% |
| Q3 2023 | $148,709,648 | +19.7% | 5,889,491 | 0.0% | 14.07% | +40.2% |
| Q2 2023 | $124,268,260 | +23.8% | 5,889,491 | 0.0% | 10.04% | +20.7% |
| Q1 2023 | $100,415,822 | -14.4% | 5,889,491 | +0.3% | 8.32% | -16.8% |
| Q4 2022 | $117,308,394 | -6.8% | 5,871,291 | +0.5% | 10.00% | +0.6% |
| Q3 2022 | $125,802,000 | +9.2% | 5,840,398 | 0.0% | 9.95% | -0.9% |
| Q2 2022 | $115,173,000 | -16.7% | 5,840,398 | -0.7% | 10.04% | -6.0% |
| Q1 2022 | $138,211,000 | -15.8% | 5,881,299 | -2.4% | 10.68% | +1.9% |
| Q4 2021 | $164,140,000 | -1.0% | 6,025,706 | +0.1% | 10.49% | +4.8% |
| Q3 2021 | $165,766,000 | -3.2% | 6,019,106 | 0.0% | 10.00% | +6.0% |
| Q2 2021 | $171,304,000 | -13.6% | 6,019,106 | +3.3% | 9.44% | -16.5% |
| Q1 2021 | $198,383,000 | -2.4% | 5,824,507 | -4.6% | 11.30% | +6.1% |
| Q4 2020 | $203,268,000 | +4.8% | 6,105,980 | +1.2% | 10.66% | +0.1% |
| Q3 2020 | $193,899,000 | +17.3% | 6,032,956 | +0.5% | 10.64% | +7.2% |
| Q2 2020 | $165,303,000 | +70.3% | 6,002,289 | -0.9% | 9.92% | +22.1% |
| Q1 2020 | $97,072,000 | -40.6% | 6,055,623 | -11.6% | 8.13% | -9.7% |
| Q4 2019 | $163,548,000 | +28.1% | 6,848,760 | -5.4% | 9.00% | +5.9% |
| Q3 2019 | $127,707,000 | -36.8% | 7,239,649 | -8.3% | 8.51% | -13.4% |
| Q2 2019 | $202,007,000 | -9.2% | 7,890,917 | +3.1% | 9.82% | +5.8% |
| Q1 2019 | $222,491,000 | +121.6% | 7,653,617 | 0.0% | 9.28% | +73.6% |
| Q4 2018 | $100,415,000 | -32.5% | 7,653,617 | +4.0% | 5.35% | -11.1% |
| Q3 2018 | $148,764,000 | -13.1% | 7,357,283 | +1.7% | 6.01% | -12.1% |
| Q2 2018 | $171,145,000 | +6.1% | 7,236,583 | +1.1% | 6.84% | -0.8% |
| Q1 2018 | $161,234,000 | -19.3% | 7,159,590 | +11.8% | 6.90% | -19.8% |
| Q4 2017 | $199,695,000 | +3.7% | 6,404,586 | +3.8% | 8.60% | +6.0% |
| Q3 2017 | $192,622,000 | +99.7% | 6,171,816 | +9.8% | 8.11% | +80.1% |
| Q2 2017 | $96,470,000 | -0.4% | 5,621,816 | +1.6% | 4.50% | -1.7% |
| Q1 2017 | $96,903,000 | +34.5% | 5,534,150 | +1.6% | 4.58% | +11.4% |
| Q4 2016 | $72,057,000 | -2.5% | 5,446,516 | +7.0% | 4.11% | -4.3% |
| Q3 2016 | $73,926,000 | +48.3% | 5,091,298 | +0.7% | 4.29% | +14.1% |
| Q2 2016 | $49,839,000 | -17.9% | 5,054,713 | +5.5% | 3.76% | -20.1% |
| Q1 2016 | $60,699,000 | -30.2% | 4,790,800 | 0.0% | 4.71% | -2.6% |
| Q4 2015 | $86,953,000 | -1.8% | 4,790,800 | +0.5% | 4.84% | +13.7% |
| Q3 2015 | $88,557,000 | -23.4% | 4,768,800 | +0.7% | 4.26% | -17.2% |
| Q2 2015 | $115,595,000 | +19.5% | 4,733,601 | +1.8% | 5.14% | +7.5% |
| Q1 2015 | $96,709,000 | +35.1% | 4,649,448 | +0.5% | 4.78% | +13.8% |
| Q4 2014 | $71,559,000 | +40.9% | 4,625,648 | +18.8% | 4.20% | +10.7% |
| Q3 2014 | $50,793,000 | +164.2% | 3,892,199 | +304.6% | 3.80% | +165.2% |
| Q2 2014 | $19,223,000 | +59.4% | 962,101 | +51.9% | 1.43% | +186.8% |
| Q1 2014 | $12,060,000 | +142.8% | 633,398 | +116.8% | 0.50% | +7.8% |
| Q4 2013 | $4,967,000 | +19.5% | 292,199 | +9.7% | 0.46% | +6.2% |
| Q3 2013 | $4,157,000 | +30.5% | 266,299 | 0.0% | 0.44% | +16.0% |
| Q2 2013 | $3,185,000 | – | 266,299 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 955,462 | $24,460,000 | 13.75% |
| Foresite Capital Management IV, LLC | 1,561,185 | $39,966,000 | 11.30% |
| Asymmetry Capital Management, L.P. | 730,440 | $18,699,000 | 10.13% |
| NEXTHERA CAPITAL LP | 470,741 | $12,051,000 | 10.04% |
| Palo Alto Investors LP | 7,890,917 | $202,007,000 | 9.82% |
| Vivo Capital, LLC | 1,748,174 | $44,753,000 | 4.19% |
| ACUTA CAPITAL PARTNERS, LLC | 435,500 | $11,149,000 | 3.96% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $9,111,000 | 3.38% |
| Consonance Capital Management LP | 1,711,150 | $43,805,000 | 3.10% |
| Opus Point Partners Management, LLC | 26,936 | $690,000 | 1.02% |